Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,275 | 131 | 69.7% |
| Consulting Fee | $975.00 | 1 | 29.9% |
| Travel and Lodging | $16.05 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie, Inc. | $1,623 | 36 | $0 (2019) |
| Janssen Biotech, Inc. | $239.61 | 12 | $0 (2019) |
| Gilead Sciences, Inc. | $230.61 | 15 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $225.99 | 13 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $200.30 | 10 | $0 (2019) |
| Shionogi Inc | $107.82 | 6 | $0 (2019) |
| Ironwood Pharmaceuticals, Inc | $104.00 | 6 | $0 (2018) |
| Intercept Pharmaceuticals, Inc. | $74.55 | 4 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $71.41 | 3 | $0 (2017) |
| Allergan Inc. | $68.28 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $399.61 | 22 | AbbVie, Inc. ($132.81) |
| 2018 | $930.37 | 53 | Janssen Biotech, Inc. ($198.06) |
| 2017 | $1,936 | 58 | AbbVie, Inc. ($1,301) |
All Payment Transactions
133 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/30/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | APRISO (Drug), TRULANCE | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/18/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/22/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Endocrinology | ||||||
| 05/22/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $0.57 | General |
| Category: Endocrinology | ||||||
| 04/30/2019 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Immunology | ||||||
| 04/24/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.15 | General |
| 04/15/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/03/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Endocrinology | ||||||
| 03/28/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/27/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.57 | General |
| 03/13/2019 | Shionogi Inc | Mulpleta (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 03/07/2019 | Braintree Laboratories, Inc. | MOTOFEN (Drug), SUPREP BOWEL PREP | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: GASTROENTEROLOGY - DIARRHEA | ||||||
| 03/06/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Virology | ||||||
| 02/26/2019 | Shionogi Inc | Mulpleta (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 02/21/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Endocrinology | ||||||
| 02/20/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.92 | General |
| 02/19/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Immunology | ||||||
| 02/06/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Virology | ||||||
| 01/24/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $17.88 | General |
| 01/17/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Immunology | ||||||
| 01/16/2019 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 01/09/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.75 | General |
| 12/24/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/20/2018 | Shionogi Inc | Mulpleta (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 12/19/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXANIBSD (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: GASTROENTEROLOGY | ||||||
About Dr. Stephen Severance, M.D
Dr. Stephen Severance, M.D is a Specialist healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619983848.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Severance, M.D has received a total of $3,266 in payments from pharmaceutical and medical device companies, with $399.61 received in 2019. These payments were reported across 133 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,275).
Practice Information
- Specialty Specialist
- Location Long Beach, CA
- Active Since 07/31/2006
- Last Updated 08/25/2015
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1619983848
Products in Payments
- Viekira (Drug) $1,171
- Humira (Biological) $240.02
- STELARA (Biological) $239.61
- XIFAXAN (Drug) $157.72
- ZEPATIER (Drug) $143.12
- Creon (Drug) $120.97
- LINZESS (Drug) $104.00
- Mavyret (Drug) $91.29
- Trulance (Drug) $68.11
- Mulpleta (Drug) $60.91
- OCALIVA (Drug) $54.31
- UCERIS (Drug) $52.12
- Symproic (Drug) $46.91
- DIFICID (Drug) $46.71
- PREPOPIK (Drug) $44.21
- Entyvio (Biological) $39.06
- ZENPEP (Drug) $37.15
- Cimzia (Drug) $36.77
- VIBERZI (Drug) $31.13
- MOTOFEN (Drug) $27.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Long Beach
David Morrison, M.d, M.D
Specialist — Payments: $4.9M
Peter Kurzweil, M.d, M.D
Specialist — Payments: $511,121
Dan Tran, M.d, M.D
Specialist — Payments: $394,164
Dr. David Shavelle, M.d, M.D
Specialist — Payments: $88,220
Philip Yuan, M.d, M.D
Specialist — Payments: $59,461
Dr. Nilesh Vora, M.d, M.D
Specialist — Payments: $18,049